NMRA: Neumora Therapeutics Inc

NMRA新闻

• 14:46 Stifel maintains Hold rating on Neumora Therapeutics stock at $2.00
• 06:41 Neumora Therapeutics, Inc. (NMRA) Q2 2025 Earnings Call Transcript
• 23:46 Neumora (NMRA) Q2 Loss Improves 10%
• 14:31 Boston Beer Posts Better-Than-Expected Earnings, Joins Scholastic, Deckers Outdoor, Saia And Other Big Stocks Moving Higher On Friday - Aon (NYSE:AON), Bel Fuse (NASDAQ:BELFA)
• 11:05 Neumora Therapeutics soars 68% following InvestingPro’s June Fair Value signal
• 10:40 Mizuho raises Neumora Therapeutics stock price target on new drug candidate
• 11:41 H.C. Wainwright reiterates Buy rating on Neumora Therapeutics stock
• 11:04 Neumora begins phase 1 trial of schizophrenia drug NMRA-861
• 20:12 NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
• 18:12 ROSEN, LEADING INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA
• 16:36 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA
• 14:03 Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy' - Johnson & Johnson (NYSE:JNJ)
• 17:45 Neumora Therapeutics shares fall as company adjusts depression drug trials
• 16:37 Neumora Therapeutics, Inc. (NMRA) Q4 2024 Earnings Call Transcript